午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

TargetMol Chemicals Inc.??? ?? ??? ?????.

?? ?:TargetMol Chemicals Inc.
??:-
???:marketing@targetmol.cn
??:China
URL: https://www.targetmol.cn/
? ?? ?:21849

?? ????

TrkB-IN-11609067-49-3C19H16N2O6
FHND50712761152-16-1C30H30D3N9O
AChE-IN-311325209-07-1
A-12931021565759-96-7
SA09-Cu155641-16-0
JT0022238820-43-2C20H24N4O5S
SHP2-IN-222802453-88-7C23H22Cl2N8O
Anticancer agent 1052450987-57-0C25H25N3O6S.K
VU03647391244639-78-8C26H27FN4O2
Urease-IN-6362502-79-2C18H19N3OS
Propargyl-PEG4-GGFG-DXd2762518-94-3C54H63FN8O15
PD-L1-IN-22894733-91-4C33H38N4O6
vc-PABC-DM11416792-90-9C53H75ClN8O13S
Osivelotor2417955-18-9C20H22N2O6
MethylCBI-azaindole-benzamide-MOM-Boc-ethylenediamine-D2222445-87-4C44H51ClN6O10
(R)-Necrocide 11247028-62-1C23H27NO3
α-Glucosidase-IN-282949513-10-2
HDAC-IN-592944459-43-0
D1R antagonist 12983777-67-7C22H26BrNO4
JG-232640819-75-4C19H16ClN3OS2
Clezutoclax1949843-71-3C83H102N12O24S2
FLT3-IN-192237234-48-7C22H26N8O
MEL24642072-48-8C17H18N4O3
P2X3-IN-12823331-49-1
Ferric nitrilotriacetate???????????16448-54-7C6H6FeNO6
WH-10417-0992769753-42-4C52H62N8O13S
Nurr1 agonist 487645-58-7C12H10O4
Mal-PEG2-Gly-Gly-Phe-Gly-Exatecan1599439-54-9C57H65FN10O15
Val-Ala-PABC-Exatecan2845164-91-0
QR-02171027786-12-4C19H13NO3
Maytansinoid B1628543-40-7C36H51ClN4O10
MC-Gly-Gly-Phe-Gly-amide-cyclopropanol-amide-Exatecan2414254-41-2C54H58FN9O13
NK3R-IN-12854331-14-7C17H16FN5OS
CCT3747052640647-90-9C21H18ClF3N4O2
CYT2961799392-31-6C18H16O2S
Mps1-IN-6 (Compound 9)2489220-49-5C24H27N7O2
SC2391977557-97-3C65H84N10O11
(2S,3R)-Voruciclib hydrochloride1253647-46-9C22H19ClF3NO5.ClH
MiTMAB2253617-91-1C17H38BrN
KRAS G12C mutant protein inhibitor A-12658538-04-4C31H26ClF4N7O2
PBR28253307-65-2C21H20N2O3
NH2-methylpropanamide-Exatecan TFA1817857-35-4C28H29FN4O5.C2HF3O2
(Aminooxy)acetamide-Val-Cit-PAB-MMAE2446645-88-9C60H97N11O14
β-catenin-IN-61039731-99-1C22H19ClN6O
Antifungal agent 482142003-75-4C13H10O4S
(RS)-K202915618-92-5
UZH1b2814392-17-9C32H42N6O3
Necrocide 11247028-61-0C23H27NO3
GPR52 receptor modulator 12642079-89-6C19H14F4N4O
Fosnetupitant chloride monohydrochloride1643757-72-5C31H36F6N4O5P. HCl. Cl
(1R,4S)-Yimitasvir diphosphate2734870-15-4
DNA Gyrase-IN-82925308-76-3C19H14BrN5O
COX-2-IN-301160498-08-7
Mal-PEG8-Val-Ala-PAB-Exatecan2679821-39-5C66H85FN8O20
Glucocerebrosidase-IN-1 hydrochloride2279945-77-4
I-2872014368-93-3C30H30ClFN4O4
TAM5581802499-21-3C79H122N14O19S
Mal-EGGGG-PEG8-amide-bis(deoxyglucitol)2360920-01-8C55H94N10O31
HP210728039-52-9C22H19N3O2S2
KRAS G12D mutation regulator 42621927-57-7C33H33FN6O2
Val-Ala-PAB-MMAE1912408-92-4C55H88N8O11
SIMR30302708270-99-7C27H29N3O2
Xeniafaraunol A161162-29-4C20H28O2
STAT3 degrader-22497583-03-4C59H62N9O13P
BET-IN-162089390-09-8
MAO-IN-3797805-26-6C42H54N4O4
Antifungal agent 502896209-33-7C25H20ClN5O2S
DprE1-IN-92906099-98-5
PPARδ agonist 9928023-21-6C26H28ClF3N4O3S
IDO1/TDO-IN-62948772-71-0C20H17NO5
H3B-9682912294-90-5C22H18F6N4O4S
HDAC-IN-602944459-58-7
Antitumor agent-972654024-16-3C24H34O3
VEGFR2-IN-3417717-09-0C26H28ClN5O4
BET-IN-142243669-93-2C30H37N7O2
GSK7372748687-95-6C20H21N5O2
Farletuzumab ecteribulin2407465-18-1
Azilsartan mepixetil potassium2153458-32-1C36H34N6O8.K
JAK-IN-262417134-93-9C22H24N6O3
α-Glucosidase-IN-292949513-11-3
PI5P4Kα-IN-12428737-31-7C20H17N3O2S
Mc-Alanyl-Alanyl-Asparagine-PAB-MMAE1638970-46-3C67H101N11O16
NSC 28838761369-43-5C19H16N4O3
MKA0312951012-00-1C21H17N5O2S
PRMT5-IN-292242788-69-6C18H19Cl2N5O5.ClH
ZL-22012865115-39-3C19H21N9O2.CH4O3S
GGFG-amide-glycol-amide-Exatecan2866301-18-8C43H47FN8O11
SN38-COOH2170118-23-5C26H24N2O8
XMT-1519 conjugate-12720500-19-4C101H149N23O42
ZINC00784494317328-17-9C20H14N2O3S
Glucocorticoid receptor agonist-2 Ala-Ala-Mal2166376-64-1C47H50F2N4O12
NaPi2b-IN-22227445-31-8C41H47ClF3N5O5S
CHI-000-667905794-70-9C21H16ClNO4S
Antifungal agent 491414861-21-4C15H12O4
(S,R)-CFT86342704617-95-6C37H45F3N6O5
INX-SM-62734878-16-9C32H36N2O6S
AM841871978-21-1C26H39NO3S
IDO1-IN-222126853-16-3
Nrf2-IN-36325-13-9C22H26N4O4S
MAT2A-IN-102924825-23-8C27H24F2N6O4
Copyright 2019 ? ChemicalBook. All rights reserved